Evidence map›Paper›PMID 28540499›Full record

ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2017

Cell-Based Therapies with T Regulatory Cells.

Mateusz Gliwiński, Dorota Iwaszkiewicz-Grześ, Piotr Trzonkowski

Abstract readReview
In one paragraph

Review in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Administration of CD4BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2021
    Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Viruses · 2025
    Article
  7. Review
  8. Role of Th2, Th17 and Treg Cells and relevant cytokines in pathogenesis of allergic rhinitis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Article
  9. Improving regulatory T cell production through mechanosensing.Journal of biomedical materials research. Part A · 2024
    Article
  10. Crucial Role ofDiagnostics (Basel, Switzerland) · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Improving the Efficacy of Regulatory T Cell Therapy.Clinical reviews in allergy & immunology · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mateusz GliwińskiDepartment of Clinical Immunology and Transplantology, Medical University of Gdańsk, Dębinki 7, 80-210, Gdańsk, Poland.ORCID http://orcid.org/0000-0001-9376-3231
Dorota Iwaszkiewicz-GrześDepartment of Clinical Immunology and Transplantology, Medical University of Gdańsk, Dębinki 7, 80-210, Gdańsk, Poland.
Piotr TrzonkowskiDepartment of Clinical Immunology and Transplantology, Medical University of Gdańsk, Dębinki 7, 80-210, Gdańsk, Poland. ptrzon@gumed.edu.pl.

Funding

Narodowe Centrum Badań i Rozwoju LIDER/160/L-6/14/NCBR/2015Narodowe Centrum Badań i Rozwoju STRATEGMED1/233368/1/NCBR/2014
6 · The paper itself

Abstract

CD4

Indexed as

AbataceptAnimalsCell TransplantationClinical Trials as TopicGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansImmunosuppressive AgentsMiceOrgan TransplantationT-Lymphocytes, RegulatoryAbataceptImmunosuppressive Agents

Identifiers

PMID28540499
PMCPMC5548816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.